Biogen-Idec

Tysabri (humanized monoclonal raised against selected leukocyte integrins) Biogen Idec/Elan Treatment of patients with relapsing forms of MS... [Pg.381]

Biogen IDEC. Alefacept (Amevive ) Product Insert, 2005. [Pg.141]

Avonex (interferon beta- Biogen-Idec la) [CHO-expressed glycoprotein-recombinant human interferon beta-la]... [Pg.309]

Biogen IDEC Rituxan (Rituximab) Chimeric Antineoplastic 1997... [Pg.419]

Biogen IDEC Zevalin (Ibritumomab tiuxetan) Murine Antineoplastic 2002... [Pg.419]

Avonex Interferon-a Biogen IDEC Multiple sclerosis 1997... [Pg.69]

IFNp-la an FDA approved therapy for relapsing remit dng muldple sclerosis. IFNp-a is available as Avonex (Biogen-Idec) 33 meg for indamuscular injecdon (IM) once a w eek and Rbif (Serono) w ith doses of 22 meg and 44 meg for sub-cuntaneous (SQ) injecdon 3x/w eek. [Pg.777]

Natalizumab Tysabri Biogen Idec/Elan humanized mAb VLA4 multiple sclerosis 2004 lgG4 6-10% ... [Pg.1152]

Rituxan Biogen-IDEC 1997 Liquid and infusion IV infusion... [Pg.429]

Avonex (Biogen-Idec, Cambridge, MA) Rebif (Serono, Rockland, MA) Betaseron (Berlex Laboratories, Montville, NJ) Betaferon (Schering, Berlin, Germany)... [Pg.827]

Davies, K. Biogen-Idec s innovation incubator. Bio-IT World, January 18, 2007. Available at www.bio-itworld.com/newsitems/2007/01 -18-07-biogen-idee ... [Pg.107]

This work was supported by the National Institutes of Health (grant ROl GM061666), Biogen IDEC (Cambridge, MA), and Shire Human Genetic Therapies (Cambridge, MA). [Pg.239]

Dr. Marco A. Biamonte Medicinal Chemistry BIOGEN IDEC 5200 Research Place San Diego, CA 92122... [Pg.867]

Ibritumomab tiuxetan Zevaltn Murine CD20 (chelate linker for In or Y Lymphoma Biogen IDEC... [Pg.250]

Rituximab Rituxan Chimeric CD20 Lymphoma Biogen IDEC... [Pg.250]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...